Phase III randomized evaluation of 13-cis-retinoic acid (cRA) [isotretinoin] plus procarbazine versus procarbazine alone in the treatment of patients with recurrent primary malignant gliomas.
Withdrawn prior to enrolment
Phase of Trial: Phase III
Latest Information Update: 21 Feb 2012
At a glance
- Drugs Isotretinoin (Primary) ; Procarbazine (Primary)
- Indications Anaplastic astrocytoma; Glioblastoma; Glioma; Gliosarcoma; Oligodendroglioma
- Focus Therapeutic Use
- 28 Sep 2010 Status changed from active, no longer recruiting to withdrawn prior to recruitment as reported by ClinicalTrials.gov.
- 20 Sep 2005 New trial record.